Daptomycin disrupts membrane potential in growing Staphylococcus aureus
- PMID: 1666494
- PMCID: PMC245372
- DOI: 10.1128/AAC.35.11.2282
Daptomycin disrupts membrane potential in growing Staphylococcus aureus
Abstract
Daptomycin (LY146032) caused a calcium-dependent dissipation of the membrane potential (delta psi) in Staphylococcus aureus without noticeably affecting the chemical gradient (delta pH) across the membrane. The effect of daptomycin on membrane energization may account for many of the inhibitory effects on macromolecular biosyntheses and membrane function reported for this antibiotic. Our evidence indicates that the bactericidal activity of daptomycin is dependent on an available delta psi.
Similar articles
-
Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus.Antimicrob Agents Chemother. 2003 Aug;47(8):2538-44. doi: 10.1128/AAC.47.8.2538-2544.2003. Antimicrob Agents Chemother. 2003. PMID: 12878516 Free PMC article.
-
Inhibition of peptidoglycan biosynthesis in gram-positive bacteria by LY146032.Antimicrob Agents Chemother. 1987 Jul;31(7):1093-9. doi: 10.1128/AAC.31.7.1093. Antimicrob Agents Chemother. 1987. PMID: 2821889 Free PMC article.
-
In vitro postantibiotic effect of daptomycin (LY146032) against Enterococcus faecalis and methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains.Antimicrob Agents Chemother. 1989 Aug;33(8):1198-200. doi: 10.1128/AAC.33.8.1198. Antimicrob Agents Chemother. 1989. PMID: 2552901 Free PMC article.
-
Insights and clinical perspectives of daptomycin resistance in Staphylococcus aureus: A review of the available evidence.Int J Antimicrob Agents. 2015 Sep;46(3):278-89. doi: 10.1016/j.ijantimicag.2015.05.008. Epub 2015 Jun 19. Int J Antimicrob Agents. 2015. PMID: 26143590 Review.
-
Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions.Lancet Infect Dis. 2009 Oct;9(10):617-24. doi: 10.1016/S1473-3099(09)70200-2. Lancet Infect Dis. 2009. PMID: 19778764 Review.
Cited by
-
Pharmacodynamics of daptomycin in a murine thigh model of Staphylococcus aureus infection.Antimicrob Agents Chemother. 2001 Mar;45(3):845-51. doi: 10.1128/AAC.45.3.845-851.2001. Antimicrob Agents Chemother. 2001. PMID: 11181370 Free PMC article.
-
Systemic antibacterial activity of novel synthetic cyclic peptides.Antimicrob Agents Chemother. 2005 Aug;49(8):3302-10. doi: 10.1128/AAC.49.8.3302-3310.2005. Antimicrob Agents Chemother. 2005. PMID: 16048940 Free PMC article.
-
Preparation and characterization of flexible nanoliposomes loaded with daptomycin, a novel antibiotic, for topical skin therapy.Int J Nanomedicine. 2013;8:1285-92. doi: 10.2147/IJN.S41695. Epub 2013 Mar 24. Int J Nanomedicine. 2013. PMID: 23569376 Free PMC article.
-
Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin.Antimicrob Agents Chemother. 2006 Apr;50(4):1581-5. doi: 10.1128/AAC.50.4.1581-1585.2006. Antimicrob Agents Chemother. 2006. PMID: 16569891 Free PMC article.
-
Complicated skin and soft tissue infections: literature review of evidence for and experience with daptomycin.Infect Drug Resist. 2011;4:115-27. doi: 10.2147/IDR.S13808. Epub 2011 May 24. Infect Drug Resist. 2011. PMID: 21753891 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases